Results 131 to 140 of about 1,095 (189)

Phase 1 multicenter study of the NKG2A targeting antibody S095029 as a single agent and in combination with anti-PD-1 in patients with advanced malignancies. [PDF]

open access: yesJ Immunother Cancer
Naing A   +11 more
europepmc   +1 more source

Comprehensive Next Generation Sequencing Reveals that Purported Primary Squamous Cell Carcinomas of the Parotid Gland are Genetically Heterogeneous. [PDF]

open access: yesHead Neck Pathol
Bishop JA   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy